Loss of NPM2 expression is a potential immunohistochemical marker for malignant peritoneal mesothelioma: a single-center study of 92 cases

BACKGROUND: Malignant peritoneal mesothelioma (MPM) is a rare malignant tumor with a high mortality rate and extremely poor prognosis. In-depth pathological analysis is essential to assess tumor biological behaviors and explore potential therapeutic targets of MPM. Nucleoplasmin 2 (NPM2) is a molecu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, He-liang, Yang, Zhi-ran, Su, Yan-dong, Ma, Ru, Du, Xue-mei, Gao, Ying, Li, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9590226/
https://www.ncbi.nlm.nih.gov/pubmed/36280841
http://dx.doi.org/10.1186/s12957-022-02811-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9590226/
https://www.ncbi.nlm.nih.gov/pubmed/36280841
http://dx.doi.org/10.1186/s12957-022-02811-y

Ejemplares similares